← Back to Search

Culturally Targeted SARS-CoV-2 Communication for COVID-19

N/A
Waitlist Available
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 weeks
Awards & highlights

Study Summary

This trial will focus on how to best communicate with African Americans in Flint, Michigan about getting a SARS-CoV-2 antibody test through a drive-up saliva sample collection.

Eligible Conditions
  • COVID-19

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anticipatory Racism
Salivary Kit Completion
Salivary Kit Request
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: African American Registry: Culturally TargetedExperimental Treatment1 Intervention
African American participants receive culturally targeted video information about SARS-CoV-2 antibody testing.
Group II: White Flint Registry: GeneralActive Control1 Intervention
White participants receive "general consumption" video information about SARS-CoV-2 antibody testing.
Group III: African American Registry: GeneralActive Control1 Intervention
African American participants receive "general consumption" video information about SARS-CoV-2 antibody testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Culturally Targeted SARS-CoV-2 Communication
2021
N/A
~530

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,721 Previous Clinical Trials
40,964,533 Total Patients Enrolled
39 Trials studying COVID-19
1,900,221 Patients Enrolled for COVID-19
Johns Hopkins UniversityOTHER
2,275 Previous Clinical Trials
14,840,099 Total Patients Enrolled
34 Trials studying COVID-19
26,436 Patients Enrolled for COVID-19
Michigan State UniversityLead Sponsor
187 Previous Clinical Trials
606,447 Total Patients Enrolled
2 Trials studying COVID-19
380 Patients Enrolled for COVID-19
~137 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top